Alterola Biotech (Alterola Biotech) Net Issuance of Debt : $0.91 Mil (TTM As of Dec. 2023)

View and export this data going back to 2009. Start your Free Trial

What is Alterola Biotech Net Issuance of Debt?

Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive. Alterola Biotech's net issuance of debt for the three months ended in Dec. 2023 was $0.50 Mil. Its net issuance of debt for the trailing twelve months (TTM) ended in Dec. 2023 was $0.91 Mil.

Alterola Biotech Net Issuance of Debt Historical Data

The historical data trend for Alterola Biotech's Net Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alterola Biotech Net Issuance of Debt Chart

Alterola Biotech Annual Data

Trend

Sep13

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Mar22

Mar23

Net Issuance of Debt

Get a 7-Day Free Trial

0.02

-0.38

1.17

Alterola Biotech Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Net Issuance of Debt	Get a 7-Day Free Trial															0.80	0.12	0.11	0.18	0.50

Alterola Biotech Net Issuance of Debt Calculation

This is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Net Issuance of Debt for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.91 Mil.

Alterola Biotech Net Issuance of Debt Related Terms

Thank you for viewing the detailed overview of Alterola Biotech's Net Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Alterola Biotech (Alterola Biotech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alterola Biotech Inc (OTCPK:ABTI) » Definitions » Net Issuance of Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

47 Hamilton Square, Birkenhead, Merseyside, GBR, CH41 5AR

Website

https://www.alterolabio.com

Alterola Biotech Inc is a development stage company. The company develops chewing gums to deliver nutraceutical/functional ingredients for applications such as appetite suppressant, cholesterol suppressant, vitamin delivery, antioxidant delivery, and motion sickness suppressant.

Executives

Bright Green Corp

10 percent owner

401 EAST LAS OLAS BLVD., SUITE 1400, FT. LAUDERDALE FL 33301